Adipotide (FTPP)
Targeted fat cell apoptosis for body composition
Overview
Adipotide is a peptidomimetic that targets and destroys the blood supply to fat tissue by binding to prohibitin on the surface of blood vessels feeding white adipose tissue, inducing apoptosis of fat cells.
Mechanism of Action
Binds prohibitin on vascular endothelium → triggers apoptosis in adipose vasculature → fat cell death via ischemia → reduction in white adipose tissue mass.
Benefits
- Targeted fat cell destruction
- Rapid body composition changes
- Reduces white adipose tissue
- Preserves lean mass
- Unique mechanism of action
Dosing Protocol
Half-Life
~72 hours
Duration of pharmacological activity after administration.
Side Effects
- Renal stress (monitor kidney function)
- Dehydration
- Fatigue
- Injection site reactions
Stacking Recommendations
Storage & Reconstitution
Refrigerate at 2–8°C. Reconstituted solution stable for 28 days refrigerated.
Research Notes
Showed dramatic fat loss in primate studies (up to 39% reduction in 28 days). Renal side effects are a significant concern. Not FDA-approved. Research-use only.
Medical Disclaimer
This information is provided for educational and research purposes only. It is not intended as medical advice, diagnosis, or treatment recommendations. Peptide therapy should only be initiated under the supervision of a qualified healthcare provider. Individual results may vary. Always consult with your physician before starting any new therapy. Regulatory status varies by jurisdiction.